You are here: Welcome to the MPKB » Welcome to the MPKB » Science behind Marshall Paradigm » Science behind immunopathology
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:protocol:immunopathology [08.21.2017] – [Immunopathology reveals disease] sallieqhome:protocol:immunopathology [10.13.2018] – [Related publications and presentations] sallieq
Line 134: Line 134:
 In observing a set of worsening symptoms, patients and clinicians may be tempted to assume that the disease itself is worsening. Even a small number of researchers are mistakenly convinced that antibiotics cause or exacerbate chronic disease. The best example of this may be so-called "minocycline-induced lupus."(({{pubmed>long:17366961}})) In fact, there is no reasonable mechanism, proven or theoretical, which explains how minocycline, the primary action of which is to block the 30s ribosome of bacteria, can cause lupus – or any other disease.(({{pubmed>long:17511865}})) Nor is there a mechanism by which olmesartan can cause porphyria cutanea tarda (a blood disorder) as was reported in a 2010 //Journal of the European Academy of Dermatology and Venereology// paper.(({{pubmed>long:20015057}})) In observing a set of worsening symptoms, patients and clinicians may be tempted to assume that the disease itself is worsening. Even a small number of researchers are mistakenly convinced that antibiotics cause or exacerbate chronic disease. The best example of this may be so-called "minocycline-induced lupus."(({{pubmed>long:17366961}})) In fact, there is no reasonable mechanism, proven or theoretical, which explains how minocycline, the primary action of which is to block the 30s ribosome of bacteria, can cause lupus – or any other disease.(({{pubmed>long:17511865}})) Nor is there a mechanism by which olmesartan can cause porphyria cutanea tarda (a blood disorder) as was reported in a 2010 //Journal of the European Academy of Dermatology and Venereology// paper.(({{pubmed>long:20015057}}))
  
-Edward L. Krawitt, M.D. has it right when he suggests the possibility that minocycline, an MP antibiotic, "unmasks" autoimmune hepatitis.(({{pubmed>long:16394302}})) +Edward L. Krawitt, M.D. has it right when he suggests the possibility that minocycline, "unmasks" autoimmune hepatitis.(({{pubmed>long:16394302}})) 
  
 In the same vein, an “allergic” reaction to minocycline or any of the other antibiotics formerly used with Olmesartan was invariably due to the immunopathological response generated by taking olmesartan (Benicar) and antibiotics.  In the same vein, an “allergic” reaction to minocycline or any of the other antibiotics formerly used with Olmesartan was invariably due to the immunopathological response generated by taking olmesartan (Benicar) and antibiotics. 
Line 169: Line 169:
  
  
-{{tag>Science_behind_Protocol}}+{{tag>Science_behind_Protocol IP Microbes_in_the_human_body}}
 ===== Notes and comments ===== ===== Notes and comments =====
  
home/protocol/immunopathology.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.